News

News
Partner news

On Target Laboratories secures $40 million financing led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC)

Read full story
Partner news

Fusion Pharmaceuticals Completes Oversubscribed Series A Financing Totaling $46 Million USD to Develop Targeted Alpha Therapeutics

Read full story
Partner news

Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets

Read full story
Partner news

Accelerator Corporation Announces Series A Financing in Rodeo Therapeutics to Focus on Small-Molecule Regenerative Therapies

Read full story
Partner news

BlackThorn Therapeutics Enrolls First Patient in Phase 2a Study of Lead Compound, BTRX-246040, in Major Depressive Disorder

Read full story
Partner news

E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline

Read full story
Partner news

Provention Bio, Inc. Appoints Eleanor L. Ramos, MD, as Chief Medical Officer and Chief Operating Officer

Read full story
Partner news

Provention Bio, Inc. Secures $28.4 Million Founding Financing to Fund Development Targeting the Interception and Prevention of Immune-Mediated Disease

Read full story
Partner news

Aelix Therapeutics appoints HIV expert as CMO

Read full story
Partner news

FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation

Read full story
Partner news

Ethicon Announces Agreement to Acquire Torax Medical, Inc.

Read full story
Partner news

Verb Surgical Delivers Digital Surgery Prototype Demonstration to Collaboration Partners

Read full story
Partner news

BlackThorn Therapeutics Secures $14 Million in Series A Extension Financing

Read full story